Top

Published in:

01-07-2016 | Short Communication

Influence of new antiretrovirals on hematological toxicity in HIV-exposed uninfected infants

Authors: Núria Rovira, Antoni Noguera-Julian, Susana Rives, Rubén Berrueco, Rebeca Lahoz, Clàudia Fortuny

Published in: European Journal of Pediatrics | Issue 7/2016

Abstract

Maternal combined antiretroviral therapy (cART) successfully prevents HIV mother-to-child transmission but also causes hematological toxicity in the HIV-exposed uninfected (HEU) infant. We performed a single-center prospective observational study. Hematological toxicity during the first year of life (at 3 and 6 weeks, and 3, 6, and 12 months) was compared between HEU infants born in two different time periods: P1 (2000–2001) and P2 (2007–2013). Mother-infant pairs in P1 (n = 55) and P2 (n = 48) mainly differed in maternal ethnic origin, HIV route of transmission, and cART regimens. Anemia and neutropenia were both less common in P2 than P1, albeit not significantly. Earlier normalization of red blood cell mean corpuscular volume levels in P2 infants suggests that current cART maternal regimens and shorter neonatal prophylaxis are less toxic. Leukocyte, lymphocyte, and platelet counts remained within normal values during follow-up, without differences between groups.

Conclusion: New cART regimens have had very little impact on the hematological toxicity in HEU infants.

What is Known:

• Antiretroviral drugs during pregnancy and the neonatal period very effectively prevent mother-to-child transmission of HIV infection.

• Hematological toxicity has been widely reported among HIV-exposed uninfected children.

What is New:

• In HIV-exposed uninfected children, hematological toxicity is still mainly caused by exposure to zidovudine.

• New antiretroviral drugs have very little impact on hematological toxicity among HIV-exposed uninfected children.

Bridges EG, Trentesaux C, Lahlil R, Spiga MG, Jeannesson P, Sommadossi JP (1996) 3′-Azido-3′-deoxythymidine inhibits erytroid- specific transcription factors in human erythroid K562 leukemia cells. Eur J Haematol 56:62–67CrossRefPubMed

Bunders MJ, Bekker V, Scherpbier J, Boer K, Godfried M, Kuijpers TW (2005) Haematological parameters of HIV-1-uninfected infants born to HIV-1-infected mothers. Acta Paediatr 94:1571–1577CrossRefPubMed

Connor E, Sperling R, Gelber R, Kiselev P, Scott G, O’Sullivan M, VanDyke R, Bey M, Shearer W, Jacobson R et al (1994) Reduction of maternal infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 331:1173–1180CrossRefPubMed

Dainiak N, Worthington M, Riordan MA, Kreczko S, Goldman L (1988) 3′-Azido-3′-deoxythymidine (AZT) inhibits proliferation in vitro of human haematopoietic progenitor cells. Br J Haematol 69:299–304CrossRefPubMed

Dryden-Peterson S, Shapiro RL, Hughes MD, Powis K, Ogwu A, Moffat C, Moyo S, Makhema J, Essex M, Lockman S (2011) Increased risk of severe infant anemia after exposure to maternal HAART, Botswana. J Acquir Immune Defic Syndr 56:428–436CrossRefPubMedPubMedCentral

Gogu SR, Malter JS, Agrawal KC (1992) Zidovudine-induced blockade of the expression and function of the erythropoietin receptor. Biochem Pharmacol 44:1009–1012CrossRefPubMed

Grupo de expertos de la Secretaría del Plan Nacional sobre el Sida (SPNS), Grupo de Estudio de Sida (GeSIDA)/Sociedad Española de Ginecología y Obstetricia (SEGO) y Sociedad Española de Infectología Pediátrica (SEIP) (2013) Documento de consenso para el seguimiento de la infección por el VIH en relación con la reproducción, embarazo, parto y profilaxis de la transmision vertical del niño expuesto. Available at: http://www.msssi.gob.es/ciudadanos/enfLesiones/enfTransmisibles/sida/publicaciones/profSanitarios/DocEmbarazoMarzo2013.pdf. Accessed 3 Dec 2015

Jones CE, Naidoo S, De Beer C, Esser M, Kampmann B, Hesseling AC (2011) Maternal HIV infection and antibody responses against vaccine-preventable diseases in uninfected infants. J Am Med Assoc 305:576–584CrossRef

Lahoz R, Noguera A, Rovira N, Català A, Sánchez E, Jimenez R, Fortuny C (2010) Antiretroviral-related hematologic short-term toxicity in healthy infants. Implications of the new neonatal 4-week zidovudine regimen. Pediatr Infect Dis J 29:376–379PubMed

10.

Le Chenadec J, Mayaux MJ, Guihenneuc-Jouyaux C, Blanche S, Enquête Périnatale Française Study Group (2003) Perinatal antiretroviral treatment and hematopoiesis in HIV-uninfected infants. AIDS 17:2053–2061CrossRefPubMed

11.

Lewis LD, Amin S, Civin CI, Letman PS (2004) Ex vivo zidovudine (AZT) treatment of CD34+ bone marrow progenitors causes decreased steady state mitochondrial DNA (mtDNA) and increased lactate production. Hum Exp Toxicol 23:173–185CrossRefPubMed

12.

National Institute for Allergy and Infectious Disease (NIAID), Division of AIDS. Table for grading the severity of adult and pediatric adverse events, version 2.0 (2014). Available at: http://rsc.tech-res.com/Document/safetyandpharmacovigilance/DAIDS_AE_Grading_Table_v2_NOV2014.pdf. Accessed 3 Dec 2015

13.

Pollack S, Weaver J (1993) Azidothymidine (AZT)-induced siderosis. Am J Hematol 43:230–233CrossRefPubMed

14.

Sollay S, Noguera Julian A, Galli L, Fortuny C, Deyà A, de Martino M, Chiappini E (2015) Strategies for the prevention of mother to child transmission in western countries. Pediatr Infect Dis J 34:S14–S30CrossRef

15.

Stevens GA, Finucane MM, De-Regil LM, Paciorek CJ, Flaxman SR, Branca F, Peña-Rosas JP, Bhutta ZA, Ezzati M, Nutrition Impact Model Study Group (Anaemia) (2013) Global, regional, and national trends in haemoglobin concentration and prevalence of total and severe anaemia in children and pregnant and non-pregnant women for 1995–2011: a systematic analysis of population-representative data. Lancet Glob Health 1:e16–e25CrossRefPubMedPubMedCentral

16.

Taron-Brocard C, Le Chenadec J, Faye A, Dollfus C, Goetghebuer T, Gajdos V, Labaume JM, Perilhou A, Mandelbrot L, Blanche J et al (2014) Increased risk of serious bacterial infections due to maternal immunosuppression in HIV-exposed uninfected infants in a European country. Clin Infect Dis 59:1332–1345CrossRefPubMed

17.

Vigilancia Epidemiológica del VIH/SIDA en España. Actualización 30 de Junio de 2014. Instituto de Salud Carlos III, Gobierno de España. Available at: http://www.msssi.gob.es/ciudadanos/enfLesiones/enfTransmisibles/sida/vigilancia/InformeVIHSida_Junio2014.pdf. Accessed 3 Dec 2015

Title: Influence of new antiretrovirals on hematological toxicity in HIV-exposed uninfected infants
Authors: Núria Rovira
Antoni Noguera-Julian
Susana Rives
Rubén Berrueco
Rebeca Lahoz
Clàudia Fortuny
Publication date: 01-07-2016
Publisher: Springer Berlin Heidelberg
Published in: European Journal of Pediatrics / Issue 7/2016
Print ISSN: 0340-6199
Electronic ISSN: 1432-1076
DOI: https://doi.org/10.1007/s00431-016-2730-x

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Influence of new antiretrovirals on hematological toxicity in HIV-exposed uninfected infants

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 7/2016

Pressurised metered dose inhaler-spacer technique in young children improves with video instruction

Cardiac arrest in infants, children, and adolescents: long-term emotional and behavioral functioning

Enduring large use of acetaminophen suppositories for fever management in children: a national survey of French parents and healthcare professionals’ practices

Impact of healthcare-associated sepsis on mortality in critically ill infants

Occurrence of subdural hematomas in Dutch glutaric aciduria type 1 patients

Inflammatory pseudotumor (IPT)—surgical cure of an inflammatory syndrome